Annual CAPEX
$13.20 K
-$120.60 K-90.13%
31 December 2023
Summary:
Lipocine annual capital expenditures is currently $13.20 thousand, with the most recent change of -$120.60 thousand (-90.13%) on 31 December 2023. During the last 3 years, it has risen by +$5600.00 (+73.68%). LPCN annual CAPEX is now -90.13% below its all-time high of $133.80 thousand, reached on 31 December 2022.LPCN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Lipocine quarterly capital expenditures is not available.LPCN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Lipocine TTM capital expenditures is not available.LPCN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPCN CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +73.7% | - | - |
5 y5 years | - | - | - |
LPCN CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -90.1% | +73.7% | ||||
5 y | 5 years | -90.1% | +73.7% | ||||
alltime | all time | -90.1% | +73.7% |
Lipocine CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $13.20 K(-90.1%) | $9200.00(>+9900.0%) | $13.20 K(-86.9%) |
Sept 2023 | - | $0.00(0.0%) | $100.70 K(0.0%) |
June 2023 | - | $0.00(-100.0%) | $100.70 K(-9.3%) |
Mar 2023 | - | $4000.00(-95.9%) | $111.00 K(-17.0%) |
Dec 2022 | $133.80 K(+1660.5%) | $96.70 K(>+9900.0%) | $133.80 K(+260.6%) |
Sept 2022 | - | $0.00(-100.0%) | $37.10 K(0.0%) |
June 2022 | - | $10.30 K(-61.6%) | $37.10 K(+38.4%) |
Mar 2022 | - | $26.80 K(>+9900.0%) | $26.80 K(-55.0%) |
Dec 2021 | $7600.00 | - | - |
Dec 2016 | - | $0.00(0.0%) | $59.60 K(0.0%) |
Sept 2016 | - | $0.00(-100.0%) | $59.60 K(-18.9%) |
June 2016 | - | $20.40 K(-48.0%) | $73.50 K(+34.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | $39.20 K(>+9900.0%) | $54.60 K(+90.9%) |
Dec 2015 | - | $0.00(-100.0%) | $28.60 K(-57.2%) |
Sept 2015 | - | $13.90 K(+826.7%) | $66.90 K(-7.6%) |
June 2015 | - | $1500.00(-88.6%) | $72.40 K(+2.1%) |
Mar 2015 | - | $13.20 K(-65.5%) | $70.90 K(+19.0%) |
Dec 2014 | - | $38.30 K(+97.4%) | $59.60 K(+179.8%) |
Sept 2014 | - | $19.40 K(>+9900.0%) | $21.30 K(+587.1%) |
June 2014 | - | $0.00(-100.0%) | $3100.00(0.0%) |
Mar 2014 | - | $1900.00(>+9900.0%) | $3100.00(+158.3%) |
Dec 2013 | - | $0.00(-100.0%) | $1200.00(-110.7%) |
Sept 2013 | - | $1200.00(-109.7%) | -$11.20 K(-9.7%) |
Dec 2012 | - | -$12.40 K | -$12.40 K |
FAQ
- What is Lipocine annual capital expenditures?
- What is the all time high annual CAPEX for Lipocine?
- What is the all time high quarterly CAPEX for Lipocine?
- What is the all time high TTM CAPEX for Lipocine?
What is Lipocine annual capital expenditures?
The current annual CAPEX of LPCN is $13.20 K
What is the all time high annual CAPEX for Lipocine?
Lipocine all-time high annual capital expenditures is $133.80 K
What is the all time high quarterly CAPEX for Lipocine?
Lipocine all-time high quarterly capital expenditures is $96.70 K
What is the all time high TTM CAPEX for Lipocine?
Lipocine all-time high TTM capital expenditures is $133.80 K